We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > T-cell

News List

AbbVie and Calibr partner to develop T-cell therapies for cancer pharmaceutical-technology
June 28, 2018
AbbVie has formed an alliance with Scripps Research’s non-profit drug discovery unit Calibr to develop next-generation T-cell therapies that are aimed at targeting various cancers, including solid tumours.
GSK makes T-cell move pharmatimes
September 11, 2017
GSK has exercised its option to exclusively license the right to research, develop, and commercialise Adaptimmune's NY-ESO SPEAR T-cell therapy programme, from a collaboration and license agreement signed in 2014.
Artificial T-cell receptors market pharmaasia
July 04, 2017
Futuristic application of Therapeutics expecting 44% CAGR during 2016-2023: Occams Business Research & Consulting Pvt. Ltd.